Hpv-associated Oropharyngeal Squamous Cell Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2017-11-13
Clinical Trial Update: Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma [Phase 1, Phase 2]
A clinical trial evaluating cetuximab, cisplatin, and BYL719 for HPV-associated oropharyngeal squamous cell carcinoma has been withdrawn.